Document Page: First | Prev | Next | All | Image | This Release | Search
File: 123096_sep96_decls7_0005.txt
Subject: PREVENTION AND TREATMENT OF NERVE AGENT POISONING
Unit: VAR. BUMED
Parent Organization: BUMED
Box ID: BX303902
Folder Title: PREVENTION AND TREATMENT OF NERVE AGENT POISONING
Document Number: 1
Folder Seq #: 14
UNCLASSIFIED
FM 8-285/NAVMED P-5041/AFM 160-11
the U.S. Air Force, each person is authorized to
@,,.,@edi@alpersonnel,ortheindividualadministering
he Mark I carry three sets of the Mark I kit for the treatment
tiveness of of nerve agent poisoning. The U.S. Navy, however,
inistered to does not use the Mark I but, rather. its antidote
lybysome- components are issued as three atropine and two 2
entilation. PAM Cl auto-injectors per person.
C. Protection Agai7zst I-reezing. The atropine and
2-10. The Nerve Agent Antidote Kit, the2PAMCIsolutionsfreezeatabout3O'F.There:
@.,Mcrrk. I
fare. when'the temperature lsbelow freezing. the
The Nerve Agent Antidote Kit, Mark I (fig H - 1). is Mark I injectors should be protected against freez-
the antidote used by the Army and the Air Force in ing. Auto-injectors issued to the individual service
the treatment of nerve agent poisoning. member are normally carried in the protective
mask carrier. During cold weather when the tem-
NOT@ perature is below freezing, the injectors should be
The U.S. Navy does not use the Mayk I. carried in an inside poc@et close to the body. (If the
Instead, the Navy issues 3 atropine and 2 Mark I injectors getfrozen, they can be thawed and
pralidoxirit chloride auto-injectors per used.)
person.
sts of Lour 2-@l 1. Pxin@Mies in the-Use of.the Nerve
-a. Dwriptim T-h J.@t. c@
separate components: the atropine avto-injector,- Agent Antidote Kit, Mark I
the pralidoxime chloride auto-injector. the plastic The following are principles to be followed in the
clip. and the foam carrying case. administration of the Nerve Agent Antidote. Mark
(I)The-atropine auto-injector consistsof a hard I (fig H-1).
plastic tube co nta ining 2 mg (0.7 MI) of atrop ine in
- - - a. Self-Aid If you expcsrienee mosf or all of the
solution. it has a pressure activated coiled spring MILD symptoms ef nerve agent poisoning (p-ar'a'
mechanism which irigkers the needle for injection 2-5)..You should IMMEDIATELY stop breathing
of tne7&ntidote solutions The container is white plas- (DO NOT INHALE) and put on your protective
tic with green identification and directions labels mask. Then administer one set of the Nerve Agent
ntoyou'r lateral thigh muscle
tic attached to the clip at the rear of the container. (orbuttocks). (Self-aid procedure for administering
The needle end is a green plastic cap which, when the au@injectors is found in app H.)
pressure isapplied.activatesthespring mechanism. (1) Wait 10 to 15 minutes after giving yourself
(2)The2PAMClauto-injectorisahardplastic thefirst set of injections since it takes that long for
tube which dispenses 600 mg/2 ml of 2 PAM Cl (300 the antidote to take effect. If you are ship, to ambu-
mg/ml) solution when activated. It has a pressure late. know who you are and where you are. you will
activated coil spring mechanism identical to that in not need a second set of Mark I injections.
the atropine abto-injector. The container is clear
plastic with a light brown identification label with WARNING
black lettering. Label directions are black on a Giving yourself a second set of injections
white background. The safety cap is gray plastic may create a nerve agent antidote over-
attached to the clip at the rear of the container. The dose. which could result in incapacitation.
needle end is black plastic. (2) If symptoms of nerve agent poisoning are
(3) The clip is made of clear hard plastic con- not relieved after administering one set of Mark I
structed to hold the pair of auto-injectors together injections. seek someone else to check your symp-
ill have to administer the second
are held flush to the bottom of the plastic clip by a and third sets of injections, if needed, since you
movable metal retaining flange. The clip container probably will be unable to administer them to
re@ses ire labeled'@ith-W;i@'k numbdrs@ "17 for the yourself.
atropine and "2" for the 2 PAM Cl auto-injector. b. Buddy Aid. If you encounter a service member
(4) The foam envelope is a charcoal gray form- suffering from SEVE RE signs of nerve agent poi-
fitting case with pressed seams which is designed to soning (para 2-5), render the following aid.
carry both auto-injectors. The envelope is used for (1) Mask the casualty, it necessary. Do not
shipping purposes only and is removed by the ser- fasten the hood.
vice members prior to putting the injectors in their (2) Administer. in rapid succession. three sets
mask carrier. of the Mark I. Follow administration procedureout-
b. Issue toservice Members. In the U.S. Army and lined in appendix H.
2-13
UNCLASSIFIED
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 11 f:/Week-44/BX303902/PREVENTION AND TREATMENT OF NERVE AGENT POISONING/prevention and treatment of nerve agent poisonin:1217960956196
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-44
Box ID = BX303902
Unit = VAR. BUMED
Parent Organization = BUMED
Folder Title = PREVENTION AND TREATMENT OF NERVE AGENT POISONING
Folder Seq # = 14
Subject = PREVENTION AND TREATMENT OF NERVE AGENT POISONIN
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996